Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 137,961 | reported | 06 Feb 2017 | tx 95+1,509,200−633,667 |
| Travere Therapeutics, Inc. | 29,000 | reported | 08 May 2019 | tx 10+105,000 |
| aTYR PHARMA INC | 20,000 | reported | 08 May 2019 | tx 4+92,000 |
| FATE THERAPEUTICS INC | 16,000 | reported | 03 May 2019 | tx 7+158,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2019 | GRANT_AWARD | Travere Therapeutics, Inc. | 2,000 | 0.00 USD | |
| 08 May 2019 | GRANT_AWARD | Travere Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 03 May 2019 | GRANT_AWARD | FATE THERAPEUTICS INC | 16,000 | — | deriv |
| 15 May 2018 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 09 May 2018 | GRANT_AWARD | Travere Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 09 May 2018 | GRANT_AWARD | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 02 May 2018 | GRANT_AWARD | FATE THERAPEUTICS INC | 16,000 | — | deriv |
| 17 May 2017 | GRANT_AWARD | Travere Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 17 May 2017 | GRANT_AWARD | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 09 May 2017 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 02 May 2017 | GRANT_AWARD | FATE THERAPEUTICS INC | 25,000 | — | deriv |
| 07 Apr 2017 | GRANT_AWARD | aTYR PHARMA INC | 32,000 | 0.00 USD | deriv |
| 06 Feb 2017 | SALE | NEUROCRINE BIOSCIENCES INC | 963 | 43.14 USD | |
| 03 Feb 2017 | SALE | NEUROCRINE BIOSCIENCES INC | 1,500 | 42.55 USD | |
| 17 Jan 2017 | SALE | NEUROCRINE BIOSCIENCES INC | 1,750 | 40.65 USD | |
| 10 Jan 2017 | SALE | NEUROCRINE BIOSCIENCES INC | 1,750 | 43.37 USD | |
| 23 Nov 2016 | PURCHASE | FATE THERAPEUTICS INC | 56,390 | 2.66 USD | |
| 18 May 2016 | GRANT_AWARD | Travere Therapeutics, Inc. | 2,000 | 0.00 USD | |
| 18 May 2016 | GRANT_AWARD | Travere Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 11 May 2016 | GRANT_AWARD | FATE THERAPEUTICS INC | 25,000 | — | deriv |
| 05 Feb 2016 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 48,500 | 0.00 USD | deriv |
| 05 Feb 2016 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 10,200 | 0.00 USD | deriv |
| 05 Feb 2016 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 20,500 | 0.00 USD | deriv |
| 03 Feb 2016 | SALE | NEUROCRINE BIOSCIENCES INC | 1,500 | 38.06 USD |